Related Experiment Video

Updated: Nov 1, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.8K

Regarding HER2-Amplified Biliary Tract Cancer

Shubham Pant1

  • 1Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

The Oncologist
|June 22, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.1K
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

41.9K

Related Experiment Videos

Last Updated: Nov 1, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.8K
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.1K
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

41.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K

Articles linked to this work by shared authors, journal, and citation graph.

Impact of Tumor Multifocality on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma: Implications for Future Staging Systems.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.

JCO precision oncology·2026

Durvalumab with Gemcitabine and Oxaliplatin in Advanced Biliary Tract Cancer.

Cancers·2026

Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response.

JCO precision oncology·2026

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.

The New England journal of medicine·2026

Molecular and Immune Correlates of Lymphocyte Activation Gene-3 Expression in Renal Cell Carcinoma.

The oncologist·2026

Lifestyle Patterns and Sleep Disturbance Among Black Breast Cancer Survivors: Results from the Women's Circle of Health Follow-Up Study.

The oncologist·2026

Association of SGLT2 Inhibitor Use with Clinical Outcomes in Patients Receiving Immune Checkpoint Inhibitors: A Pan-Tumor Propensity-Matched Analysis.

The oncologist·2026

Genomic Landscape and Therapeutic Implications of ALK Fusion-Positive Colorectal Cancer.

The oncologist·2026

Oncofertility in Gastrointestinal (GI) Oncology - A Pan-European study of the patient perspective.

The oncologist·2026

A Silent Gap: Underrepresentation of Latin American Patients in Pivotal Genitourinary and Skin Cancer Trials.

The oncologist·2026

Cancer-associated myositis: a single-centre 20-year experience.

Clinical rheumatology·2026

From black-box prediction to transparent insight: the status quo and paradigm shift of explainable artificial intelligence in hepatocellular carcinoma research.

Journal of the Egyptian National Cancer Institute·2026

An integrated methodological roadmap for real-world biomarker studies: advancing oncology precision medicine through robust methodologies and machine learning integration.

Journal of biopharmaceutical statistics·2026

Path Analysis of the Cancer Mueller Matrix: From Physical Decomposition to High-Dimensional Vector Mapping.

Journal of biophotonics·2026

Time to Diagnosis Among Children and Adolescents With Cancer in Québec, Canada: A Population-Based Study.

Pediatric blood & cancer·2026

Diagnostic Accuracy of Soft Tissue Cytology and Risk of Malignancy Across the IAC-IARC-WHO Six-Tier Reporting System: A Systematic Review and Meta-Analysis With Retrospective Category Mapping.

Diagnostic cytopathology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us